NHS hospitals are piloting Abbott’s VOLT device, a catheter-based treatment for atrial fibrillation — the UK’s most common heart rhythm disorder, affecting an estimated 1.5 million people. Dr Riyaz Somani, Consultant Cardiologist at University Hospitals of Leicester NHS Trust, explains how the device uses pulsed field ablation to target faulty heart tissue more precisely than traditional methods, reducing risk to surrounding structures while allowing more patients to be treated per day — often with same-day discharge.

Watch the BBC News Interview below: